CA2940065A1 - Methode de production rapide d'anticorps monoclonaux a haute affinite - Google Patents

Methode de production rapide d'anticorps monoclonaux a haute affinite Download PDF

Info

Publication number
CA2940065A1
CA2940065A1 CA2940065A CA2940065A CA2940065A1 CA 2940065 A1 CA2940065 A1 CA 2940065A1 CA 2940065 A CA2940065 A CA 2940065A CA 2940065 A CA2940065 A CA 2940065A CA 2940065 A1 CA2940065 A1 CA 2940065A1
Authority
CA
Canada
Prior art keywords
mice
high affinity
antigen
lymphocytes
adjuvant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2940065A
Other languages
English (en)
Inventor
Rob Beecroft
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MindWalk Holdings Corp
Original Assignee
Immunoprecise Antibodies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunoprecise Antibodies Ltd filed Critical Immunoprecise Antibodies Ltd
Priority to CA2940065A priority Critical patent/CA2940065A1/fr
Publication of CA2940065A1 publication Critical patent/CA2940065A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
CA2940065A 2016-08-22 2016-08-22 Methode de production rapide d'anticorps monoclonaux a haute affinite Abandoned CA2940065A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2940065A CA2940065A1 (fr) 2016-08-22 2016-08-22 Methode de production rapide d'anticorps monoclonaux a haute affinite

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA2940065A CA2940065A1 (fr) 2016-08-22 2016-08-22 Methode de production rapide d'anticorps monoclonaux a haute affinite

Publications (1)

Publication Number Publication Date
CA2940065A1 true CA2940065A1 (fr) 2018-02-22

Family

ID=61241969

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2940065A Abandoned CA2940065A1 (fr) 2016-08-22 2016-08-22 Methode de production rapide d'anticorps monoclonaux a haute affinite

Country Status (1)

Country Link
CA (1) CA2940065A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110054689A (zh) * 2019-05-10 2019-07-26 上海钹乐诗生物技术有限公司 一种快速大量制备HbA1c单克隆抗体的方法
CN114340660A (zh) * 2019-08-30 2022-04-12 豪夫迈·罗氏有限公司 开发用于发现治疗性抗体的高效杂交瘤平台

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110054689A (zh) * 2019-05-10 2019-07-26 上海钹乐诗生物技术有限公司 一种快速大量制备HbA1c单克隆抗体的方法
CN114340660A (zh) * 2019-08-30 2022-04-12 豪夫迈·罗氏有限公司 开发用于发现治疗性抗体的高效杂交瘤平台

Similar Documents

Publication Publication Date Title
Kaushal et al. Monoclonal antibodies against surface determinants on gametes of Plasmodium gallinaceum block transmission of malaria parasites to mosquitoes.
NO319013B1 (no) Vaksine omfattende type I overflateantigener fra Staphylococcus epidermidis, samt hyperimmune globuliner og antistoff rettet mot type I-overflateantigenet.
JP6877143B2 (ja) インフルエンザワクチンおよび治療
Franke et al. Pan DR binding sequence provides T-cell help for induction of protective antibodies against Plasmodium yoelii sporozoites
CN102256620A (zh) 用于治疗阿尔茨海默氏病的免疫治疗组合物
EP1569688B1 (fr) VACCIN CONTENANT UN ANTIGENE CONJUGUE A DES ANTICORPS ANTI-CD40& xA;. DE FAIBLE VALENCE
CN113082202B (zh) 一种复合水溶性动物疫苗佐剂和疫苗以及疫苗的制备方法
Elbahnasawy et al. Co-delivery of a CD4 T cell helper epitope via covalent liposome attachment with a surface-arrayed B cell target antigen fosters higher affinity antibody responses
EP0142345A2 (fr) Vaccin anti-idiotypique à base d'anticorps monoclonaux anti-idiotypiques
CA2940065A1 (fr) Methode de production rapide d'anticorps monoclonaux a haute affinite
WO2019133647A1 (fr) Combinaison d'un vaccin à protéine de fusion avec un anticorps anti-ox40 destinée à être utilisée pour déclencher des réponses immunitaires spécifiques de l'antigène
Patarroyo et al. Immune response of bovines stimulated by synthetic vaccine SBm7462® against Rhipicephalus (Boophilus) microplus
Benne et al. Influenza virus neutralizing antibodies and IgG isotype profiles after immunization of mice with influenza A subunit vaccine using various adjuvants
WO2015165368A1 (fr) Anticorps monoclonal anti-her2 à action de neutralisation, et utilisation de celui-ci
JP2012505229A (ja) 自己抗イディオタイプワクチンを用いてｂ細胞イディオタイプに対する持続的免疫応答を誘導するための方法
CN108948185B (zh) 蒜氨酸抗原及其免疫应答获得的家兔蒜氨酸抗体
Robinson et al. Palmitic acid conjugation of a protein antigen enhances major histocompatibility complex class II-restricted presentation to T cells
Rodriguez et al. Priming and boosting determinants on the antibody response to an Epidermal Growth Factor-based cancer vaccine
CN115232798B (zh) 一种杂交瘤细胞株5B3、恙虫病东方体56kDa蛋白单克隆抗体及其制备方法与应用
AT410636B (de) Verfahren zur herstellung eines impfstoffes
Arif et al. Immunopotentiation of outer membrane protein through anti-idiotype Pasteurella multocida vaccine in rabbits
Hirano et al. Kinetics of mouse antibody and lymphocyte responses during intranasal vaccination with a lipooligosaccharide-based conjugate vaccine
EP0370090B1 (fr) Immunogenes et peptides biologiquement actifs derives de sequences partagees d'antigenes et d'anticorps anti-idiotypiques ou d'anticorps specifiques contre des recepteurs cellulaires des antigenes
CN103159855B (zh) 融合蛋白及其用途、其抗疟疾疫苗和抗体
BR112020001586A2 (pt) vacina contra malária

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20210818

FZDE Discontinued

Effective date: 20240304